Medical Device Marketing
Medical device marketing has to satisfy a clinician, a materials manager, and a finance reviewer in the same document. We build the messaging, evidence, and demand that clear all three.
Who this is for
Device companies at first commercial launch or expanding beyond early adopter accounts, where interest is real but conversion stalls at committee.
What we build
Marketing that is designed backward from the approval it has to win.
- Value analysis committee dossier: clinical, operational, and economic case in one reviewable package
- Procedure economics and total cost narrative your finance reviewer can verify
- Clinician adoption content: training, technique, and peer proof
- Digital demand aimed at the searches specifiers actually run
- Rep enablement so field conversations match the marketing
Distribution and channel
Direct, distributor, and GPO or IDN routes each demand different marketing. We define the channel first, then build for it, rather than producing one set of assets and hoping.
Patients on the other end
Every stalled committee review is a delayed procedure improvement. Making the case clearly is not just commercial hygiene; it is how a better device reaches the people it was built for.
Common questions
Pre-clearance or post-clearance?
We work post-clearance commercial marketing, and can help prepare the commercial plan while clearance is pending.
Do you also train the sales team?
Yes. Marketing and sales training are usually the same engagement for device companies.
Can you work alongside our existing agency?
Yes. We set the strategy and brief them, which usually makes their output work harder.
Stalling at the value analysis committee?
Start with a brief 15-minute discovery call to discuss your project and confirm fit. Qualified leads are invited to a private technical session for an in-depth look at your scientific challenge.
Discuss Your Project